Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Luurtsema

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Molecular Imaging and Biology|September 24, 2004
Transport across the blood-brain barrier: stereoselectivity and PET-tracersGert Luurtsema, Elizabeth C M de Lange, Adriaan A Lammertsma, et al.
Molecular Pharmaceutics|June 5, 2015
Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain BarrierHeli Savolainen, Mariangela Cantore, Nicola A Colabufo, et al.
Chemical Communications (Cambridge, England)|December 10, 2020
Cross-coupling of [<sup>11</sup>C]methyllithium for <sup>11</sup>C-labelled PET tracer synthesisHugo Helbert, Ines Farinha Antunes, Gert Luurtsema, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 30, 2016
Evaluation of [<sup>18</sup>F]MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats: Kinetics, metabolism, and selectivityHeli Savolainen, Albert D Windhorst, Philip H Elsinga, et al.
Nuclear Medicine and Biology|August 4, 2009
Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in ratsGert Luurtsema, Robert C Schuit, Rob P Klok, et al.
Chemmedchem|November 14, 2015
(11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission TomographyMariangela Cantore, Marcel Benadiba, Philip H Elsinga, et al.
Nuclear Medicine and Biology|February 5, 2005
Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the ratGert Luurtsema, Carla F M Molthoff, Robert C Schuit, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2005
Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studiesMarc A Kropholler, Ronald Boellaard, Alie Schuitemaker, et al.
Central Nervous System Agents in Medicinal Chemistry|September 17, 2011
The role of p-glycoprotein in psychiatric disorders: a reliable guard of the brain?Onno L De Klerk, Fokko J Bosker, Gert Luurtsema, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Molecular Imaging and Biology|September 24, 2004
Transport across the blood-brain barrier: stereoselectivity and PET-tracersGert Luurtsema, Elizabeth C M de Lange, Adriaan A Lammertsma, et al.
Molecular Pharmaceutics|June 5, 2015
Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain BarrierHeli Savolainen, Mariangela Cantore, Nicola A Colabufo, et al.
Chemical Communications (Cambridge, England)|December 10, 2020
Cross-coupling of [<sup>11</sup>C]methyllithium for <sup>11</sup>C-labelled PET tracer synthesisHugo Helbert, Ines Farinha Antunes, Gert Luurtsema, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 30, 2016
Evaluation of [<sup>18</sup>F]MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats: Kinetics, metabolism, and selectivityHeli Savolainen, Albert D Windhorst, Philip H Elsinga, et al.
Nuclear Medicine and Biology|August 4, 2009
Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in ratsGert Luurtsema, Robert C Schuit, Rob P Klok, et al.
Chemmedchem|November 14, 2015
(11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission TomographyMariangela Cantore, Marcel Benadiba, Philip H Elsinga, et al.
Nuclear Medicine and Biology|February 5, 2005
Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the ratGert Luurtsema, Carla F M Molthoff, Robert C Schuit, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2005
Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studiesMarc A Kropholler, Ronald Boellaard, Alie Schuitemaker, et al.
Central Nervous System Agents in Medicinal Chemistry|September 17, 2011
The role of p-glycoprotein in psychiatric disorders: a reliable guard of the brain?Onno L De Klerk, Fokko J Bosker, Gert Luurtsema, et al.
Pageof 10